Mobile Menu

Video Category

← FOG2022 Highlights

Translating germline cancer genomics into precision prevention of cancer
Clare Turnbull, Professor of Translational Cancer Genetics, Institute of Cancer Research
Drugging the cancer genome: progress, opportunities and challenges in personalised medicine
Paul Workman, Professor of Pharmacology and Therapeutics, Institute of Cancer Research
Molecular diagnostics and the NHSE Long Term Plan for Cancer
Peter Johnson, National Clinical Director for Cancer, NHS England
Liquid biopsy: From discovery to clinical implementation
Klaus Pantel, Chairman of the Institute of Tumour Biology, University Centre Hamburg-Eppendorf
Cancer evolution, immune evasion and metastasis
Charles Swanton, Senior Group Leader, Crick Institute